Stocks Health care XCUR
NASDAQ · Health careExicure, Inc. (XCUR)
Exicure, Inc. brought in $0 of revenue over the twelve months to June 30, 2026. It posted a net loss of $8.3M. In fiscal 2025 capital spending exceeded operating cash flow by $8.6M. At June 30, 2026 it held $1.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
What Exicure, Inc. does
Exicure, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker XCUR.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $0 | -$4.9M | -$0.79 | -$8.6M |
| 2024 | $500K | -$9.7M | -$4.75 | -$2.9M |
| 2023 | $0 | -$16.9M | -$10.55 | -$10.4M |
| 2022 | $28.8M | -$2.6M | -$2.80 | -$35.7M |
| 2021 | -$483K | -$64.1M | -$108.50 | -$35.8M |
| 2020 | $16.6M | -$24.7M | -$42.19 | -$42.4M |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Exicure, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 16, 2026
- August 14, 2026
- July 17, 2026Activist stake changed SCHEDULE 13D/A
- June 30, 2026
- June 1, 2026
- May 29, 2026
- May 15, 2026Late quarterly report notice NT 10-Q
- April 10, 2026
- April 2, 2026Other event 8-K
- March 27, 2026
Insider trades
What the people running Exicure, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 8, 2026 | Exicure HiTron Inc.10% owner | Other change | 117,441 | $528.5K |
| June 26, 2026 | Exicure HiTron Inc.10% owner | Other change | 253,195 | $1.1M |
| June 24, 2026 | Exicure HiTron Inc.10% owner | Other change | 123,456 | $555.6K |
| June 23, 2026 | Exicure HiTron Inc.10% owner | Other change | 129,183 | $581.3K |
Who owns XCUR
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Exicure HiTron Inc.13D, may seek influence | 34.9% | July 17, 2026 |
Largest institutional holders
Insiders
1 insiders reported holding 2,222,224 shares in total.
| Holder | Shares |
|---|---|
| Exicure HiTron Inc.10% owner | 2,222,224 |
Questions about XCUR
What does Exicure, Inc. do?
Exicure, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker XCUR.
Is Exicure, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $8.3M.
How much revenue does Exicure, Inc. make?
Over the twelve months to June 30, 2026 Exicure, Inc. reported revenue of $0.
When did Exicure, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the stock exchange listing notice from September 16, 2026.
Similar companies
Compare XCUR with
Follow XCUR
Get an email when Exicure, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow XCUR: get an email when it filesWhere the numbers come from
Financial figures are the values Exicure, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.